Search - tctmd.com

Displaying 21 - 40 of 41

Sort: Relevancy | Date

FDA Extends Dapagliflozin Indication Across LVEF Spectrum

News Daily News

FDA Extends Dapagliflozin Indication Across LVEF Spectrum

May 09, 2023

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

News Daily News

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

May 05, 2023

Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry

News Conference News EHRA 2023

Pulsed-Field Ablation Cuts AF Recurrence at 1 Year: MANIFEST-PF Registry

Michael O'Riordan

April 25, 2023

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

April 19, 2023

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

News Daily News

AHA/ACC Scientific Statement Supports Exercise Therapy in HFpEF

March 27, 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

News Conference News THT 2023

More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field

March 24, 2023

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

News Daily News

Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives

March 24, 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

News Conference News THT 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

March 23, 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

March 22, 2023

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Presentation THT 2023

Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

Presenter: Sheldon Litwin

March 21, 2023

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort

Presentation THT 2023

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort

Presenter: Marat Fudim

March 21, 2023

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

News Daily News

Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF

March 15, 2023

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

News Conference News ACC 2023

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

March 09, 2023

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

News Conference News ACC 2023

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

March 06, 2023

Rate-Adaptive Atrial Pacing for Heart Failure with preserved Ejection Fraction: The RAPID-HF trial

Presentation ACC 2023

Rate-Adaptive Atrial Pacing for Heart Failure with preserved Ejection Fraction: The RAPID-HF trial

Presenter: Barry A. Borlaug

March 06, 2023

RAPID-HF: Rate-Adaptive Pacing Doesn’t Help in HFpEF

News Conference News ACC 2023

RAPID-HF: Rate-Adaptive Pacing Doesn’t Help in HFpEF

March 05, 2023

Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs

News Daily News

Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs

January 23, 2023

Even When Eligible, Not All Acute HF Patients Get GDMT

News Daily News

Even When Eligible, Not All Acute HF Patients Get GDMT

January 11, 2023

Top Heart Failure News of 2022

News Daily News

Top Heart Failure News of 2022

January 04, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.